A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 592,000 shares of SRRK stock, worth $26.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
592,000
Previous 590,800 0.2%
Holding current value
$26.5 Million
Previous $4.92 Million 3.66%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.63 - $9.71 $9,156 - $11,652
1,200 Added 0.2%
592,000 $4.74 Million
Q2 2024

Aug 14, 2024

BUY
$7.84 - $16.79 $4.41 Million - $9.44 Million
562,000 Added 1951.39%
590,800 $4.92 Million
Q1 2024

May 15, 2024

BUY
$13.2 - $17.76 $380,160 - $511,488
28,800 New
28,800 $511,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.31B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.